All sponsors

BioNTech SE $BNTX

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS25
PHASE 3 / 2-37
RECRUITING19
READOUTS ≤12 MONTHS5
READOUT SLIPPED >6 MO56%

Delay Index: of 18 active trials registered more than a year ago, 10 have moved their primary completion (readout) date by more than 6 months since first registration (median +13.0 months). See all sponsors →

Open BioNTech SE on the live radar map → 📅 $BNTX readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
BNT164a1
NCT05547464
P1/2Active, not recruitingTuberculosis4972026-03-12 (+17 mo)
RO7198457 intravenous (IV)
NCT04486378
P2Active, not recruitingColorectal Cancer Stage II; Colorectal Cancer Stage III3272026-11 (+38 mo)
BNT162b2
NCT07798648
P3RecruitingCOVID-19 Vaccines7002027-04-21
BNT327 Dose Level 1 (DL1)
NCT06449209
P2Active, not recruitingExtensive-stage Small-cell Lung Cancer; Small-cell Lung Cancer1102027-06 (+28 mo)
BNT166a
NCT07379580
P2RecruitingMpox (Monkeypox); Smallpox3102027-06
BNT3212
NCT07147348
P1/2RecruitingAdvanced Solid Tumor3752027-11
Pumitamig
NCT07255404
P2RecruitingPancreatic Ductal Adenocarcinoma (PDAC)1052027-12
Pumitamig
NCT07297212
P2RecruitingRecurrent Glioblastoma752028-01
BNT326
NCT07070232
P1/2RecruitingAdvanced Solid Tumor14382028-03 (-2 mo)
Fern-EC-01
NCT06340568
P3RecruitingEndometrial Cancer4802028-03 (+17 mo)
BNT327 Dose Level 1 (DL1)
NCT06449222
P2Active, not recruitingLocally Advanced Breast Cancer; Triple Negative Breast Cancer832028-08 (+42 mo)
BNT324
NCT06892548
P1/2RecruitingAdvanced Lung Cancer5942028-09 (+13 mo)
Pumitamig
NCT06841055
P2RecruitingNon-small Cell Lung Cancer602028-10
BNT326
NCT07111520
P1/2RecruitingNon-small Cell Lung Cancer8802028-11 (-2 mo)
Pumitamig
NCT06712316
P2/3RecruitingNon-small Cell Lung Cancer15802029-01 (-11 mo)
Pumitamig
NCT06712355
P3RecruitingExtensive-stage Small-cell Lung Cancer6212029-04 (+12 mo)
AHEAD-MERIT
NCT04534205
P2/3Active, not recruitingUnresectable Head and Neck Squamous Cell Carcinoma; Metastatic Head and Neck Cancer3582029-04 (+47 mo)
BNT323
NCT06827236
P1/2RecruitingLocally Advanced Breast Cancer; Unresectable Breast Carcinoma3802029-08 (+17 mo)
BNT3210
NCT07886684
P1/2Not yet recruitingAdvanced Solid Tumors1732029-10
Pumitamig
NCT07173751
P3RecruitingBreast Neoplasms5582029-12
BNT329
NCT07186842
P1/2RecruitingAdvanced Solid Cancers2452030-05
BNT3214
NCT07455734
P1/2RecruitingAdvanced Solid Tumor Cancer5332030-10
BNT314
NCT07079631
P1/2RecruitingMetastatic Colorectal Cancer4822030-12
BNT324
NCT07365995
P3RecruitingMetastatic Castration-resistant Prostate Cancer7362031-02
BNT317 DL1
NCT06750185
P1/2RecruitingAdvanced Solid Tumor2482031-04 (+34 mo)